{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T07:59:24Z","timestamp":1780905564948,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Schleswig-Holstein - Campus Kiel"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular-kidney-metabolic (CKM) syndrome has emerged as a major global health burden and driver of cardiovascular disease (CVD), the leading cause of death worldwide. Effective management of CKM depends on timely identification of underlying risk factors. Nevertheless, participation rates in primary care-based screenings are low. Consequently, CKM syndrome oftentimes remains undetected until organ damage is clinically present. Community pharmacies offer an accessible, yet underused, setting to enhance early detection. APOSCREEN-1 evaluates the feasibility and diagnostic yield of a pharmacy-based multi-parametric screening for cardiovascular-kidney-metabolic health.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      APOSCREEN-1 is a prospective single-arm clinical trial conducted in 20 community pharmacies in the German state of Schleswig-Holstein. Adults (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091000) aged\u2009\u2265\u200940 years with predefined risk criteria are included. Participants undergo standardized point-of-care testing (glycated hemoglobin, lipid profile, urinary albumin, blood pressure). Additionally, clinical history is assessed and results are transmitted to the study center via an online platform. Patients meeting pre-defined thresholds of the tested parameters are followed up by confirmatory laboratory testing at the study center or at the participants\u2019 general practitioner. Primary outcomes include completion rate, implementation metrics from the pharmacy perspective, and the number needed to screen to detect unknown or insufficiently managed cardiometabolic risk factors. Secondary outcomes comprise participant metrics, diagnostic metrics of the screening, evaluation of the clinical impact.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study aims to address the unmet need for scalable prevention of CVD by identification of CKM syndrome risk factors outside traditional primary care settings. Evidence on feasibility, acceptance, and diagnostic benefit may support the use of community pharmacies as an additional access point for early CKM syndrome detection. Future interventional studies will be required to evaluate structured follow-up pathways and long-term effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>This study was registered with the German trial registry (Deutsches Register klinischer Studien) on 29.01.2026, under trial number DRKS00039149.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-026-05090-x","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:24:38Z","timestamp":1780676678000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["APOSCREEN-1 \u2013 a prospective, single-arm clinical trial for the implementation of a pharmacy-based screening for cardiovascular-kidney-metabolic risk factors in Schleswig-Holstein"],"prefix":"10.1186","volume":"27","author":[{"given":"Eric","family":"Amelunxen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Kokot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Kolbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah-Yasmin","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja L.","family":"Me\u00dftorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Laudes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenny R.","family":"Lienhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas M.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K.","family":"Sievers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich A.","family":"von Samson-Himmelstjerna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"10513","key":"5090_CR1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/S0140-6736","volume":"406","author":"M Naghavi","year":"2025","unstructured":"Naghavi M, Kyu HH, Aalipour AB, Aalruz MA, Ababneh H. u. a. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990\u20132023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet 18 Oktober. 2025;406(10513):1811\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(25)01917-8. PubMed PMID: 41092928.","journal-title":"Lancet 18 Oktober"},{"issue":"20","key":"5090_CR2","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS. u. a. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023 Nov 14;148(20):1606\u201335. https:\/\/doi.org\/10.1161\/CIR.0000000000001184.","journal-title":"Circulation 14 November"},{"key":"5090_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12933-023","volume":"22","author":"M Marassi","year":"2023","unstructured":"Marassi M, Fadini GP. The cardio-renal-metabolic connection: a review of the evidence. Cardiovasc Diabetol 31 Juli. 2023;22:195. https:\/\/doi.org\/10.1186\/s12933-023-01937-x. PubMed PMID: 37525273; PubMed Central PMCID: PMC10391899.","journal-title":"Cardiovasc Diabetol 31 Juli"},{"issue":"1","key":"5090_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41467-025-67268-5","volume":"17","author":"JJ Noubiap","year":"2025","unstructured":"Noubiap JJ, Nansseu JR, Nyaga UF, Ndoadoumgue AL, Ngouo AT, Tounouga DN. u. a. Worldwide trends in metabolic syndrome from 2000 to 2023: a systematic review and modelling analysis. Nat Commun 6 Dezember. 2025;17(1):573. https:\/\/doi.org\/10.1038\/s41467-025-67268-5. PubMed PMID: 41350289; PubMed Central PMCID: PMC12808104.","journal-title":"Nat Commun 6 Dezember"},{"issue":"6","key":"5090_CR5","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.amjmed.2025.01.031","volume":"138","author":"JE Kim","year":"2025","unstructured":"Kim JE, Joo J, Kuku KO, Downie C, Hashemian M, Powell-Wiley. TM, u. a. Prevalence, Disparities, and Mortality of Cardiovascular-Kidney-Metabolic Syndrome in US Adults, 2011\u20132018. Am J Med Juni. 2025;138(6):970\u2013e9797. https:\/\/doi.org\/10.1016\/j.amjmed.2025.01.031. PubMed PMID: 39909293; PubMed Central PMCID: PMC12092198.","journal-title":"Am J Med Juni"},{"issue":"4","key":"5090_CR6","doi-asserted-by":"publisher","first-page":"e0249738","DOI":"10.1371\/journal.pone.0249738","volume":"16","author":"MS Bin Sayeed","year":"2021","unstructured":"Bin Sayeed MS, Joshy G, Paige E, Banks E, Korda R. Cardiovascular disease subtypes, physical disability and workforce participation: A cross-sectional study of 163,562 middle-aged Australians. PLoS ONE. 2021;16(4):e0249738. https:\/\/doi.org\/10.1371\/journal.pone.0249738. PubMed PMID: 33831054; PubMed Central PMCID: PMC8031377.","journal-title":"PLoS ONE"},{"key":"5090_CR7","unstructured":"Federal Statistical Office of Germany (Destatis). Germany has the highest health expenditure in the EU [Internet]. Wiesbaden: Destatis; year unknown. Available from: https:\/\/www.destatis.de\/Europa\/DE\/Thema\/Bevoelkerung-Arbeit-Soziales\/Gesundheit\/Gesundheitsausgaben.html. Accessed: 28.02.2026."},{"issue":"8","key":"5090_CR8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s10654-023-00995-5","volume":"38","author":"D Jasilionis","year":"2023","unstructured":"Jasilionis D, van Raalte AA, Kl\u00fcsener S, Grigoriev P. The underwhelming German life expectancy. Eur J Epidemiol. 2023;38(8):839\u201350. https:\/\/doi.org\/10.1007\/s10654-023-00995-5. PubMed PMID: 37185793; PubMed Central PMCID: PMC10129301.","journal-title":"Eur J Epidemiol"},{"key":"5090_CR9","doi-asserted-by":"publisher","first-page":"204800401668721","DOI":"10.1177\/2048004016687211","volume":"6","author":"J Stewart","year":"2017","unstructured":"Stewart J, Manmathan G, Wilkinson P. Primary prevention of cardiovascular disease: A review of contemporary guidance and literature. JRSM Cardiovasc Dis 1 Januar. 2017;6:2048004016687211. https:\/\/doi.org\/10.1177\/2048004016687211. PubMed PMID: 28286646; PubMed Central PMCID: PMC5331469.","journal-title":"JRSM Cardiovasc Dis 1 Januar"},{"issue":"24","key":"5090_CR10","doi-asserted-by":"publisher","first-page":"e533","DOI":"10.1161\/CIR.0000000000001026","volume":"144","author":"D Laddu","year":"2021","unstructured":"Laddu D, Ma J, Kaar J, Ozemek C, Durant RW, Campbell T. u. a. Health behavior change programs in primary care and community practices for cardiovascular disease prevention and risk factor management among midlife and older adults: a scientific statement from the American Heart Association. Circulation. 2021 Dec 14;144(24):e533\u201349. https:\/\/doi.org\/10.1161\/CIR.0000000000001026. PubMed PMID: 34732063; PubMed Central PMCID: PMC9188324.","journal-title":"Circulation 14 Dezember"},{"issue":"1","key":"5090_CR11","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1186\/1471-2458-14-913","volume":"14","author":"J Hoebel","year":"2014","unstructured":"Hoebel J, Starker A, Jordan S, Richter M, Lampert T. Determinants of health check attendance in adults: findings from the cross-sectional German Health Update (GEDA) study. BMC Public Health. 2014 Sept 4;14(1):913. https:\/\/doi.org\/10.1186\/1471-2458-14-913.","journal-title":"BMC Public Health 4 September"},{"issue":"10","key":"5090_CR12","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1111\/dme.13008","volume":"33","author":"C Heidemann","year":"2016","unstructured":"Heidemann C, Du Y, Paprott R, Haftenberger M, Rathmann W, Scheidt-Nave C. Temporal changes in the prevalence of diagnosed diabetes, undiagnosed diabetes and prediabetes: findings from the German Health Interview and Examination Surveys in 1997\u20131999 and 2008\u20132011. Diabet Med J Br Diabet Assoc. 2016 Oct;33(10):1406\u201314. https:\/\/doi.org\/10.1111\/dme.13008. PubMed PMID: 26498983.","journal-title":"Diabet Med J Br Diabet Assoc Oktober"},{"issue":"22","key":"5090_CR13","doi-asserted-by":"publisher","first-page":"11752","DOI":"10.3390\/ijerph182211752","volume":"18","author":"S Stolpe","year":"2021","unstructured":"Stolpe S, Kowall B, Scholz C, Stang A, Blume C. High unawareness of chronic kidney disease in Germany. Int J Environ Res Public Health. 2021 Nov 9;18(22):11752. https:\/\/doi.org\/10.3390\/ijerph182211752. PubMed PMID: 34831506; PubMed Central PMCID: PMC8623832.","journal-title":"Int J Environ Res Public Health 9 November"},{"key":"5090_CR14","doi-asserted-by":"publisher","unstructured":"Neuhauser H, Diederichs C, Boeing H, Felix SB, J\u00fcnger C, Lorbeer R. u. a. Deutsches \u00c4rzteblatt 48. Dtsch \u00c4rztebl Int. 2016 Nov 4;809\u201315. https:\/\/doi.org\/10.3238\/arztebl.2016.0809.","DOI":"10.3238\/arztebl.2016.0809"},{"key":"5090_CR15","unstructured":"German Federal Union of Associations of Pharmacists (ABDA). Pharmacies in Germany: figures, data, facts. Statistical Yearbook 2025 [Internet]. Berlin: ABDA. 2025. Available from: https:\/\/www.abda.de\/fileadmin\/user_upload\/assets\/ZDF\/Jahrbuch-ZDF-2025\/ZDF_2025_ABDA_Statistisches_Jahrbuch.pdf. Accessed: 28.02.2026."},{"issue":"1","key":"5090_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13012-017-0635-3","volume":"12","author":"BJ Weiner","year":"2017","unstructured":"Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS. u. a. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. https:\/\/doi.org\/10.1186\/s13012-017-0635-3.","journal-title":"Implement Sci 29 August"},{"issue":"3","key":"5090_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s43477-021-00019-y","volume":"1","author":"C Kien","year":"2021","unstructured":"Kien C, Griebler U, Schultes MT, Thaler KJ, Stamm T. Psychometric testing of the German versions of three implementation outcome measures. Glob Implement Res Appl. 2021 Sept 1;1(3):183\u201394. https:\/\/doi.org\/10.1007\/s43477-021-00019-y.","journal-title":"Glob Implement Res Appl 1 September"},{"issue":"1","key":"5090_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s43058-023-00505-4","volume":"4","author":"J Freund","year":"2023","unstructured":"Freund J, Piotrowski A, B\u00fchrmann L, Oehler C, Titzler I, Netter AL. u. a. Validation of the German normalisation process theory measure G-NoMAD: translation, adaptation, and pilot testing. Implement Sci Commun. 2023 Oct 16;4(1):126. https:\/\/doi.org\/10.1186\/s43058-023-00505-4.","journal-title":"Implement Sci Commun 16 Oktober"},{"issue":"1","key":"5090_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12874-018-0591-x","volume":"18","author":"TL Finch","year":"2018","unstructured":"Finch TL, Girling M, May CR, Mair FS, Murray E, Treweek S. u. a. Improving the normalization of complex interventions: part 2 - validation of the NoMAD instrument for assessing implementation work based on normalization process theory (NPT). BMC Med Res Methodol. 2018 Dec;18(1):135. https:\/\/doi.org\/10.1186\/s12874-018-0591-x.","journal-title":"BMC Med Res Methodol Dezember"},{"key":"5090_CR20","unstructured":"Update on Methods. Estimating certainty and magnitude of net benefit | United States Preventive Services Taskforce [Internet]. [zitiert 26. April 2026]. Available from: https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/about-uspstf\/methods-and-processes\/update-methods-estimating-certainty-and-magnitude-net-benefit. Accessed: 26.04.2026."},{"key":"5090_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12913-022-07577-3","volume":"22","author":"M Sekhon","year":"2022","unstructured":"Sekhon M, Cartwright M, Francis JJ. Development of a theory-informed questionnaire to assess the acceptability of healthcare interventions. BMC Health Serv Res. 2022 Mar 1;22:279. https:\/\/doi.org\/10.1186\/s12913-022-07577-3. PubMed PMID: 35232455; PubMed Central PMCID: PMC8887649.","journal-title":"BMC Health Serv Res 1 M\u00e4rz"},{"issue":"1","key":"5090_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11096-022-01492-7","volume":"45","author":"M Schulz","year":"2023","unstructured":"Schulz M, Griese-Mammen N, M\u00fcller U. Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain. Int J Clin Pharm. 2023;45(1):245\u20139. https:\/\/doi.org\/10.1007\/s11096-022-01492-7. PubMed PMID: 36394784; PubMed Central PMCID: PMC9938802.","journal-title":"Int J Clin Pharm"},{"key":"5090_CR23","unstructured":"German Medical Association (B\u00c4K); National Association of Statutory Health Insurance Physicians (KBV); Association of the Scientific Medical Societies in Germany (AWMF). National disease management guideline for type 2 diabetes: long version. Version 3.0. 2023 [Internet]. Berlin: AWMF. 2023 [cited 2026 Feb 28]. Available from: https:\/\/www.leitlinien.de\/diabetes and https:\/\/www.awmf.org."},{"key":"5090_CR24","doi-asserted-by":"publisher","unstructured":"German Medical Association (B\u00c4K); National Association of Statutory Health Insurance Physicians (KBV). Association of the Scientific Medical Societies in Germany (AWMF). National disease management guideline for hypertension \u2013 long version. Version 1.0. 2023 [Internet]. Available from: https:\/\/www.leitlinien.de\/hypertonie. Accessed: 28.02.2026. https:\/\/doi.org\/10.6101\/AZQ\/000502.","DOI":"10.6101\/AZQ\/000502"},{"issue":"38","key":"5090_CR25","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C. u. a. 2024 ESC guidelines for the management of elevated blood pressure and hypertension: developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO). Eur Heart J. 2024 Oct 7;45(38):3912\u20134018. https:\/\/doi.org\/10.1093\/eurheartj\/ehae178.","journal-title":"Eur Heart J 7 Oktober"},{"issue":"10215","key":"5090_CR26","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/S0140-6736(","volume":"394","author":"FJ Brunner","year":"2019","unstructured":"Brunner FJ, Waldeyer C, Ojeda F, Salomaa V, Kee F, Sans S. u. a. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the multinational cardiovascular risk consortium. Lancet Lond Engl. 2019 Dec 14;394(10215):2173\u201383. https:\/\/doi.org\/10.1016\/S0140-6736(19)32519-X. PubMed PMID: 31810609; PubMed Central PMCID: PMC6913519.","journal-title":"Lancet Lond Engl 14 Dezember"},{"key":"5090_CR27","doi-asserted-by":"publisher","unstructured":"Dorresteijn JAN, Visseren FLJ, Wassink AMJ, Gondrie MJA, Steyerberg EW, Ridker PM, u. a. Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score [Internet]. 2013 Jun 15. https:\/\/doi.org\/10.1136\/heartjnl-2013-303640.","DOI":"10.1136\/heartjnl-2013-303640"},{"issue":"25","key":"5090_CR28","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"SCORE2 working group and ESC Cardiovascular risk collaboration","year":"2021","unstructured":"SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021 Jul 1;42(25):2439\u201354. https:\/\/doi.org\/10.1093\/eurheartj\/ehab309. PubMed PMID: 34120177; PubMed Central PMCID: PMC8248998.","journal-title":"Eur Heart J 1 Juli"},{"issue":"28","key":"5090_CR29","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1093\/eurheartj\/ehad260","volume":"44","author":"SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration","year":"2023","unstructured":"SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration. SCORE2-diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. Eur Heart J. 2023 Jul 21;44(28):2544\u201356. https:\/\/doi.org\/10.1093\/eurheartj\/ehad260.","journal-title":"Eur Heart J 21 Juli"},{"issue":"25","key":"5090_CR30","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1093\/eurheartj\/ehab312","volume":"42","author":"SCORE2-OP working group and ESC Cardiovascular risk collaboration","year":"2021","unstructured":"SCORE2-OP working group and ESC Cardiovascular risk collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021 Jul 1;42(25):2455\u201367. https:\/\/doi.org\/10.1093\/eurheartj\/ehab312.","journal-title":"Eur Heart J 1 Juli"},{"issue":"6","key":"5090_CR31","doi-asserted-by":"publisher","first-page":"101754","DOI":"10.1016\/j.jacadv.2025.101754","volume":"4","author":"R Chang","year":"2025","unstructured":"Chang R, Parekh T, Hagan KK, Javed Z, Ostrominski JW. State-Level Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in the United States, 2011 to 2023. JACC Adv. 2025 May 1;4(6):101754. https:\/\/doi.org\/10.1016\/j.jacadv.2025.101754. PubMed PMID: 40315565; PubMed Central PMCID: PMC12084494.","journal-title":"JACC Adv 1 Mai"},{"issue":"41","key":"5090_CR32","first-page":"679","volume":"110","author":"J Hoebel","year":"2013","unstructured":"Hoebel J, Richter M, Lampert T. Social status and participation in health checks in men and women in Germany. Dtsch Arztebl Int. 2013 Oct 11;110(41):679\u201385.","journal-title":"Dtsch Arztebl Int 11 Oktober"},{"key":"5090_CR33","doi-asserted-by":"publisher","first-page":"1456320","DOI":"10.3389\/fpubh.2024.1456320","volume":"12","author":"L Ha\u00df","year":"2024","unstructured":"Ha\u00df L, Knippschild S, T\u00f6nnies T, Hoyer A, Palm R, Vo\u00df S. u. a. Projected number of people in need for long-term care in Germany until 2050. Front Public Health. 2024;12:1456320. https:\/\/doi.org\/10.3389\/fpubh.2024.1456320. PubMed PMID: 39540091; PubMed Central PMCID: PMC11558338.","journal-title":"Front Public Health"},{"issue":"12","key":"5090_CR34","doi-asserted-by":"publisher","first-page":"e0243322","DOI":"10.1371\/journal.pone.0243322","volume":"15","author":"E Nowossadeck","year":"2020","unstructured":"Nowossadeck E, Pr\u00fctz F, Teti A. Population change and the burden of hospitalization in Germany 2000\u20132040: Decomposition analysis and projection. PLoS ONE. 2020;15(12):e0243322. https:\/\/doi.org\/10.1371\/journal.pone.0243322. PubMed PMID: 33306705; PubMed Central PMCID: PMC7732063.","journal-title":"PLoS ONE"},{"issue":"9","key":"5090_CR35","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00103-019-02997-9","volume":"62","author":"H van den Bussche","year":"2019","unstructured":"van den Bussche H. Die Zukunftsprobleme der haus\u00e4rztlichen Versorgung in Deutschland: Aktuelle Trends und notwendige Ma\u00dfnahmen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 1 September. 2019;62(9):1129\u201337. https:\/\/doi.org\/10.1007\/s00103-019-02997-9.","journal-title":"Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 1 September"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05090-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05090-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05090-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T07:37:17Z","timestamp":1780904237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05090-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5090"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05090-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Christian-Albrechts-University of Kiel under the sign AZ D616\/25. The study is conducted according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S.Y.T. reports honoraria from AstraZeneca GmbH and travel support from Lilly GmbH. M.L. and K.S. report honoraria from Lilly GmbH, Boehringer Ingelheim International GmbH, AstraZeneca GmbH and Novo Nordisk Pharma GmbH. L.K.S. received honoraria and travel support from Boehringer Ingelheim, Lilly GmbH and AstraZeneca GmbH. R.S. reports honoraria from Lilly GmbH and AstraZeneca GmbH. F.A.v.S.-H. reports honoraria and travel support from Lilly GmbH and AstraZeneca GmbH. F.A.v.S.-H. and B.K. are supported by the Medical Faculty of the Christian-Albrechts-University Kiel. The other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"357"}}